首页 | 本学科首页   官方微博 | 高级检索  
     


High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy
Authors:Sarolta Leé  ,Katarina Vargová  Istvá  n Hizoh,Zsó  fia Horvá  thPetra Gulá  csi-Bá  rdos,Zsó  fia SztupinszkiAnna Apró  ,Andrea Ková  csIstvá  n Pré  da,Emese Tó  th-Zsá  mbokiRó  bert G. Kiss
Affiliation:Medical Center, Hungarian Defence Forces, Department of Cardiology, Budapest, Hungary
Abstract:
The benefit of adjusted antiplatelet therapy in patients with myocardial infarction after primary percutaneous coronary intervention is not well elucidated. We aimed to identify patients with high on treatment platelet reactivity and to gradually adjust antiplatelet therapy.
Keywords:AA, arachidonic-acid   ACEI, angiotensin-converting-enzyme inhibitor   ACS, acute coronary syndrome   ADP, adenosine-diphosphate   ARB, angiotensin-II receptor blocker   BMI, body mass index   CABG, coronary artery bypass graft   CAD, coronary artery disease   COLL, collagen   COX-1, cyclooxygenase-1   CV, coefficient of variation   DES, drug eluting stent   EPI, epinephrine   HPR, high on-clopidogrel treatment platelet reactivity   LM, left main coronary artery branch   LTA, light transmission aggregometry   MACE, major adverse coronary events   MI, myocardial infarction   NPR, normal platelet reactivity   NSTEMI, non ST segment elevation myocardial infarction   OR, odds ratio   PCI, percutaneous coronary intervention   PsNR, clopidogrel pseudo non-responder   RNR, clopidogrel real non-responder   rpm, rate per minute   SA, stable angina   STEMI, ST segment elevation myocardial infarction   TIMI, thrombolysis in myocardial infarction   UAP, unstable angina pectoris
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号